Cognitive Impairment Screening (p-Tau217 Alzheimer’s Blood Biomarker Test)
What is the p-Tau217 Biomarker Test?
Phosphorylated tau 217 (p-Tau217) is a specific protein marker found in the bloodstream that strongly correlates with the accumulation of amyloid-beta plaques and tau tangles in the brain—the hallmark signatures of Alzheimer’s disease.
By assessing p-Tau217 levels, clinicians can better evaluate the likelihood of underlying Alzheimer’s pathology before significant memory loss or cognitive decline impacts daily life.
- p-Tau217 Quantitative Blood Analysis: Measurement of blood p-Tau217 levels to assess Alzheimer’s risk.
- Sample Requirement: Single routine EDTA blood sample (approx. 3 mL).
- Preparation: No fasting necessary.
Note on Scope: This service is a targeted blood biomarker screen. It does not include genetic testing (e.g., APOE), formal memory questionnaires, cognitive performance evaluations, brain MRI, or PET imaging scans.
This non-invasive blood test is suitable for adults experiencing early memory or cognitive changes, as well as those with a family history of neurodegenerative conditions. You may consider this test if you or a loved one notice:
- Memory Slippage: Frequently forgetting recent conversations, appointments, or important tasks
- Repetitive Habits: Asking the same questions or repeating tasks within a short period
- Executive Functioning Impairment: Increased difficulty managing household finances, complex work tasks, or daily routines
- Spatial & Directional Issues: Disorientation or getting lost in familiar neighborhoods
- Language & Communication Challenges: Struggling to find common words or follow conversation flows
- Behavioral & Personality Shifts: Noticeable changes in mood, judgment, or social engagement
- Family History Concerns: Having a close family member diagnosed with Alzheimer’s or dementia alongside personal cognitive worries
1. Book Online: Select your preferred date and time slot at Seed Medical.
2.Attend Your Appointment: Visit our clinic for blood collection. No fasting is required; you may eat, drink, and take routine medications as usual.
3.Sample Collection & Processing: A trained healthcare professional will draw approximately 3 mL of blood. Your sample is safely processed and sent to our certified laboratory.
4.Receive Your Report: Your detailed laboratory report is typically available within 5 to 10 working days (turnaround times may vary depending on lab schedules and public holidays).
- Screening Tool, Not a Standalone Diagnosis: This blood test evaluates biomarker levels associated with Alzheimer’s pathology; it does not replace a full clinical diagnosis.
- Specific to Alzheimer's Pathology: p-Tau217 specifically reflects Alzheimer's-related brain changes and does not screen for other non-Alzheimer's forms of dementia or cognitive impairment.
- Understanding Results: A normal result does not fully rule out cognitive conditions caused by other factors. Conversely, an elevated result indicates a higher likelihood of pathology but does not automatically mean clinical dementia is present.
- Emergency Notice: If you or someone around you experiences sudden confusion, slurred speech, facial drooping, or limb weakness, seek immediate emergency medical attention. Do not wait for screening test results.
- This page provides general health information and should not replace professional medical advice or clinical evaluation.
1. Can the p-Tau217 test definitively diagnose Alzheimer’s Disease?
No. While p-Tau217 is one of the most reliable blood markers available today, Alzheimer’s disease cannot be diagnosed by a single blood test alone. Results must be interpreted by a doctor alongside clinical history, cognitive function assessments, and other diagnostic imaging if necessary.
2. Is cognitive impairment the same as Alzheimer’s Disease?
No. Cognitive impairment is an overarching term describing a decline in memory, language, or thinking abilities. Alzheimer’s disease is the most common cause of cognitive impairment, but other factors (such as vascular issues, mood disorders, or vitamin deficiencies) can also cause cognitive decline.
3. Do I need to fast before taking the blood test?
No fasting is needed. You may eat, drink, and take your prescribed medications normally before your visit.
4. How much blood is drawn during the procedure?
Only one standard EDTA blood tube—approximately 3 mL—is required, similar to a routine check-up blood test.
5. What does an "elevated" p-Tau217 result indicate?
An elevated p-Tau217 level indicates a higher probability of underlying Alzheimer's-related brain changes. It serves as a valuable signal for your doctor to recommend further clinical evaluation, cognitive monitoring, or lifestyle interventions.
6. Does a "normal" result mean my brain health is completely fine?
Not necessarily. A normal p-Tau217 level indicates that Alzheimer's-related tau pathology is unlikely at this time. However, memory or cognitive changes could still be related to other treatable causes, such as thyroid imbalances, sleep apnea, chronic stress, or other non-Alzheimer's conditions.
